相似文献
1
Transforming Disciplinary Traditions Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling".转化学科传统 评“卫生技术的问题与前景：早期卫生经济建模的作用”。
Int J Health Policy Manag. 2020 Jul 1;9(7):309-311. doi: 10.15171/ijhpm.2019.130.
2
Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling".技术开发早期的建模：是否需要迭代方法？评“卫生技术的问题与前景：早期卫生经济建模的作用”。
Int J Health Policy Manag. 2020 Jun 1;9(6):260-262. doi: 10.15171/ijhpm.2019.118.
3
The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement Decision-Making Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling".健康技术评估和报销决策中早期健康经济建模的潜力——评“健康技术的问题与前景：早期健康经济建模的作用”。
Int J Health Policy Manag. 2021 Feb 1;10(2):98-101. doi: 10.15171/ijhpm.2020.17.
4
Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling.卫生技术的问题与前景：早期卫生经济建模的作用。
Int J Health Policy Manag. 2019 Oct 1;8(10):575-582. doi: 10.15171/ijhpm.2019.36.
5
Early Health Economic Modelling - Optimizing Development for Medical Device Developers? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling".早期健康经济建模——优化医疗器械开发者的开发？评“健康技术的问题与前景：早期健康经济建模的作用”。
Int J Health Policy Manag. 2020 Sep 1;9(9):403-405. doi: 10.15171/ijhpm.2019.136.
6
How Useful Are Early Economic Models? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling".早期经济模型有多大用处？评“卫生技术的问题与前景：早期卫生经济建模的作用”。
Int J Health Policy Manag. 2020 May 1;9(5):215-217. doi: 10.15171/ijhpm.2019.119.
7
Expanding the Role of Early Health Economic Modelling in Evaluation of Health Technologies Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling".扩展早期健康经济建模在卫生技术评估中的作用 评“卫生技术的问题与前景：早期卫生经济建模的作用”。
Int J Health Policy Manag. 2021 Feb 1;10(2):102-105. doi: 10.15171/ijhpm.2020.18.
8
It's Not the Model, It's the Way You Use It: Exploratory Early Health Economics Amid Complexity Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling".不是模型，而是使用方式：复杂环境下的探索性早期卫生经济学评论“卫生技术的问题和前景：早期卫生经济建模的作用”。
Int J Health Policy Manag. 2021 Jan 1;10(1):36-38. doi: 10.15171/ijhpm.2020.04.
9
Characterizing the Validity and Real-World Utility of Health Technology Assessments in Healthcare: Future Directions Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling".在医疗保健中描述健康技术评估的有效性和实际效用：对“健康技术的问题与前景：早期健康经济建模的作用”的评论
Int J Health Policy Manag. 2020 Aug 1;9(8):352-355. doi: 10.15171/ijhpm.2019.132.
10
The Price of Substitute Technologies.替代技术的代价。
Value Health Reg Issues. 2019 Dec;20:154-158. doi: 10.1016/j.vhri.2019.08.474. Epub 2019 Sep 25.
引用本文的文献
1
Participants' perspective on a COVID-19 online vocal group stimulation for people with Parkinson's disease.参与者对针对帕金森病患者的新冠肺炎在线声乐团体刺激疗法的看法。
Front Rehabil Sci. 2022 Aug 2;3:951426. doi: 10.3389/fresc.2022.951426. eCollection 2022.
本文引用的文献
1
Nurturing Societal Values in and Through Health Innovations Comment on "What Health System Challenges Should Responsible Innovation in Health Address?".培养社会价值观与健康创新——评“负责任的健康创新应解决哪些卫生系统挑战？”
Int J Health Policy Manag. 2019 Oct 1;8(10):613-615. doi: 10.15171/ijhpm.2019.57.
2
Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling.卫生技术的问题与前景：早期卫生经济建模的作用。
Int J Health Policy Manag. 2019 Oct 1;8(10):575-582. doi: 10.15171/ijhpm.2019.36.
3
Introducing responsible innovation in health: a policy-oriented framework.引入健康领域的负责任创新：一个面向政策的框架。
Health Res Policy Syst. 2018 Sep 10;16(1):90. doi: 10.1186/s12961-018-0362-5.
4
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review.医疗成本效益阈值是基于什么设定的？相互冲突的观点和数据缺失：一项系统综述。
Glob Health Action. 2018;11(1):1447828. doi: 10.1080/16549716.2018.1447828.
5
Review of early assessment models of innovative medical technologies.创新医疗技术早期评估模型综述。
Health Policy. 2017 Aug;121(8):870-879. doi: 10.1016/j.healthpol.2017.06.006. Epub 2017 Jun 24.
6
Cost-effectiveness thresholds and the Brazilian Unified National Health System.成本效益阈值与巴西统一国家卫生系统
Cad Saude Publica. 2017 May 18;33(4):e00040717. doi: 10.1590/0102-311X00040717.
7
Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?低收入、中等收入和高收入国家经济评估方法的比较：差异何在及原因何在？
Health Econ. 2016 Feb;25 Suppl 1(Suppl Suppl 1):29-41. doi: 10.1002/hec.3312. Epub 2016 Jan 17.
8
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold.评估医疗保健中的成本效益：50,000 美元/QALY 阈值的历史。
Expert Rev Pharmacoecon Outcomes Res. 2008 Apr;8(2):165-78. doi: 10.1586/14737167.8.2.165.
9
What leads to better health care innovation? Arguments for an integrated policy-oriented research agenda.是什么推动了更好的医疗保健创新？关于综合性政策导向研究议程的论点。
J Health Serv Res Policy. 2008 Oct;13(4):251-4. doi: 10.1258/jhsrp.2008.007173.
10
The iterative use of economic evaluation as part of the process of health technology assessment.将经济评估作为卫生技术评估过程的一部分进行反复使用。
J Health Serv Res Policy. 1997 Jan;2(1):26-30. doi: 10.1177/135581969700200107.
Zotero 插件